Lung cancer is the top cause of cancer-related mortalities in Australia with 14,500 new cases each year. Credit: PeopleImages.com – Yuri A/Shutterstock.
Australia’s Therapeutic Goods Administration (TGA) has approved Body Vision Medical’s AI-powered advanced imaging system, LungVision, intended to improve the early diagnosis of lung cancer.
LungVision is designed to transform any C-arm [an advanced medical imaging device based on x-rays] into a three-dimensional imaging system, providing physicians with real-time navigation and improved visualisation for accurate bronchoscopic biopsies.
Its tablet interface allows for comprehensive control of the system, which includes planning and managing procedures from anywhere in the room.
The company has confirmed a collaboration with ParagonCare to distribute the system in New Zealand and Australia.
ParagonCare Capital and Service general manager Tiffany Chiew stated: “We are excited to welcome Body Vision Medical’s technology to our portfolio, as it strengthens our commitment to advancing augmented lung and respiratory medicine through cutting-edge AI.
“Body Vision’s real-time imaging technology offers remarkable opportunities, significantly enhancing the chances for earlier cancer detection and ultimately improved lung cancer survival rates.”
The system is compatible with any C-arm fluoroscope, enabling the generation of intra-procedural images that are essential for the identification of lung nodules.
Lung cancer is the top cause of cancer-related mortalities in Australia, with 14,500 new cases each year.
In July 2024, the LungVision system gained an innovative technology contract from provider-driven healthcare performance improvement company Vizient. The contract was supported by the recommendations from hospital experts on Vizient’s customer-led councils.
The company established exclusive distribution agreements with Paragon Care, Kral Medical Solutions and Prism Technologies for LungVision in August 2023.
Email newsletter icon
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.